Robotic-assisted Left Hemicolectomy for Left Colon Cancer

Colon Cancer Clinical Trial

— RALH  

Official title:

Robotic-assisted Left Hemicolectomy for Left Colon Cancer With a Medial-to-lateral Approach Orientated by AMA or AMV

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03696472
• Other study ID #: RoboticALH
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 2018
• Est. completion date: December 2020

Study information

• Verified date: October 2018
• Source: Southwest Hospital, China
• Contact: Li Chuan, M.D
• Phone: +862368754167
• Email: lee_tran[@]126.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main goal of this study is to clarify if Robotic-assisted surgery could become the standard approach in patients undergoing left colonic resection.

Patient candidates to left colonic resection were randomly assigned to Robotic(RAL) or laparoscopic(LL) approach. The surgical staff who were not involved in the study registered 30-day postoperative morbidity. Cost-benefit analysis was based on hospital days. Long-term morbidity, quality of life, and 5-year survival have also been evaluated

Description:

Robotic-assisted Left Hemicolectomy as advantages on showing the inferior mesenteric artery (IMA), protection of autonomic nerve compare to laparoscopic approach. Our experience found that operational flexibility was advantage without surgeon's position exchange.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 2
• Est. completion date: December 2020
• Est. primary completion date: November 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

Colon cancer adenocarcinoma The tumor located between the descending colon and the right 1/3 of transverse colon Tumors T3,?4?,b N0-2 Tolerance of chemotherapy ECOG 0-2

Exclusion Criteria:

With distant metastases Tumors T1-2 Complications of tumor Women during Pregnancy

Related Conditions & MeSH terms

• Colon Cancer
• Colonic Neoplasms

Intervention

Procedure:
• robotic assisted surgery
robotic assisted surgery was benefit to operation
• laparoscopic
conventional laparoscopic surgery

Locations

Country	Name	City	State
China	Southwest Hospital	Chongqing

Sponsors (1)

Lead Sponsor	Collaborator
Southwest Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	5-years overall survival rate		5 years
Secondary	Short-term morbidity rate		30 days
Secondary	Anastomosis leakage rate		6 months
Secondary	Operation Time		1 day
Secondary	Blood loss during operation		1 day
Secondary	Complication incident rate of surgery		1 day
Secondary	C-reaction protein level		7 days
Secondary	Recovery time after surgery		60 days